TherapeuticsMD (TXMD) SEC Filings & 10K Form $1.30 +0.29 (+28.71%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.22 -0.09 (-6.54%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Recent TherapeuticsMD SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView02/20/20258:07 PMTherapeuticsMD (Issuer)Walker Marlan D (Reporting)Form 4Statement of changes in beneficial ownership of securities 02/20/20258:07 PMTherapeuticsMD (Issuer)Thompson Tommy G (Reporting)Form 4Statement of changes in beneficial ownership of securities 02/20/20258:07 PMNaughton Gail K (Reporting)TherapeuticsMD (Issuer)Form 4Statement of changes in beneficial ownership of securities 02/20/20258:08 PMCollins Cooper C. (Reporting)TherapeuticsMD (Issuer)Form 4Statement of changes in beneficial ownership of securities 02/12/20253:25 PMClearline Capital LP (Filed by)TherapeuticsMD (Subject)Form SCHEDULE 13G12/05/20244:15 PMTherapeuticsMD (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/25/20244:00 PMTherapeuticsMD (Filer)Form DEF 14A10/25/20244:01 PMTherapeuticsMD (Filer)Form DEFA14A10/25/20244:02 PMTherapeuticsMD (Filer)Form ARS09/20/20244:00 PMTherapeuticsMD (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/26/20244:40 PMCollins Cooper C. (Reporting)TherapeuticsMD (Issuer)Form 4Statement of changes in beneficial ownership of securities 08/23/20245:18 PMCollins Cooper C. (Reporting)TherapeuticsMD (Issuer)Form 4Statement of changes in beneficial ownership of securities 08/12/20244:16 PMTherapeuticsMD (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/12/20243:10 PMTherapeuticsMD (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/29/20243:29 PMTherapeuticsMD (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/29/20243:32 PMTherapeuticsMD (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies Ovid Therapeutics 10Q Form Nabriva Therapeutics 10Q Form SCYNEXIS 10Q Form Kezar Life Sciences 10Q Form PepGen 10Q Form Spero Therapeutics 10Q Form OS Therapies 10Q Form Barinthus Biotherapeutics 10Q Form Alterity Therapeutics 10Q Form RAPT Therapeutics 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:TXMD) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TherapeuticsMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TherapeuticsMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TXMD Stock Alerts